Woo Raymond, the Chief Technology Officer of Ceribell, Inc., has reported several transactions involving common stock and stock options. This activity, disclosed in a recent SEC filing, is significant as it sheds light on the financial maneuvers of a key executive within the company.
Ceribell, Inc., which operates in the electromedical and electrotherapeutic apparatus sector, plays a crucial role in the industry. The reported transactions may influence investor perceptions and highlight the company’s ongoing growth strategy.
Background
Ceribell, Inc. is categorized under the electromedical and electrotherapeutic apparatus sector. The company is incorporated in Delaware and has its business address at 360 N. Pastoria Avenue, Sunnyvale, CA. The firm is publicly traded under the ticker symbol CBLL.
What the Filing Says
According to the SEC filing dated October 2, 2026, Woo Raymond reported multiple transactions that took place on October 1, 2026. These included:
- Acquisition of 4,864 shares of common stock at a price of $3.65 per share.
- Acquisition of 23 shares of common stock at a price of $4.70 per share.
- Sale of 4,887 shares of common stock at a price of $24.38 per share.
Following these transactions, Woo Raymond owns a total of 203,118 shares of common stock in Ceribell.
Impact
These transactions may affect various stakeholders, including investors and analysts who monitor executive activities for insights into the company’s performance and future direction. The reported trades were made under a Rule 10b5-1 trading plan, which allows executives to set up a predetermined schedule for buying and selling stock, thereby mitigating concerns about insider trading.
What's Next
The filing does not say what happens next.